202 results about "Injections sites" patented technology

A method is disclosed for enhanced vaccination and genetic vaccination of mammals. The vaccination is accomplished by delivering molecules such as proteins and nucleic acids into skeletal muscle and other cells residing in the skeletal muscle in vivo. The protein or nucleic acid is first injected into the muscle at one or multiple sites. Immediately or shortly after injection, electrodes are placed flanking the injection site and a specific amount of electrical current is passed through the muscle. The electrical current makes the muscle permeable, thus allowing the pharmaceutical drug or nucleic acid to enter the cell. The efficiency of transfer permits robust immune responses using DNA vaccines and produces sufficient secreted proteins for systemic biological activity to be observed.

A palm-controlled device is disclosed for injection of a substance into an organism. The device includes a palm-receiving surface for receiving a palm of a hand, the palm receiving surface being shaped so that the palm is substantially parallel to a surface of an injection site of the organism while operating the device. The palm receiving surface can also be shaped so that the palm is substantially perpendicular to a surface of the injection site. The device also includes an injector having at least one pre-filled syringe, the palm-receiving surface being cooperative with the injector such that when pressure is applied to the palm-receiving surface, the injector is actuated so as to inject contents of the at least one pre-filled syringe. Actuation of the injector is by gradual pressure; not sudden motion. Single or multiple doses of same or different medications can be included in a single injector.

A medicated module for an injection system to co-deliver at least two medicaments is disclosed. The drug delivery device includes a push rod operably connected to a dose dial button. The medicated module includes a housing having a connector configured for attachment to the drug delivery device, and the housing is configured to receive a portion of the push rod when the medicated module is attached to the drug delivery device. The medicated module further includes a reservoir in the housing comprising a single dose of a medicament and a needle guard operably connected to the housing and configured to move in an axial direction during application to an injection site. Still further, the medicated module includes a sleeve in the housing configured to move axially in the housing and a locking collar in the housing configured to move axially and rotationally in the housing.

A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed, where a drug delivery device (7) containing a primary medicament accepts a medicated module (4) containing a single dose of a second medicament (2) and where both medicaments are delivered through a single hollow needle (3). The medicated module (4) comprises two housings (21, 30) removably connected to each other, where each housing (21, 30) contains a sterile needle (3, 5) and needle needle guard assembly (34, 49) that locks out after the needle (3, 5) is inserted in an injection site.

Devices and systems for recording and/or stimulating electrical signals in order to identify a target site within a patient's brain for further electrical stimulation and chemical treatments of the brain. The deep brain stimulation devices and methods include implantable devices having various microelectrode configurations and drug delivery mechanisms. The devices can be used to treat a variety of neurological conditions.

An instrument, article and method are provided for minimizing pain during administration by injection of a liquid, such as, an anesthetic. The instrument has a forward end. A lightpipe mounted freely for vibration projects out of the forward end. The article, a single use tip, is composed of a tip sleeve removably mounted on the forward end of the instrument and a tip member removably mounted on the projecting lightpipe to vibrate a preselected injection site on a human or animal. The tip sleeve and tip member are covered by an elastic overmold that enables the tip member to vibrate freely with respect to the tip sleeve and light from the lightpipe to illuminate the injection site. A vibration unit mounted in the instrument is coupled to the lightpipe. The method is carried out by imparting vibrations and illumination via the lightpipe to the tip member.

Devices with sites that are located using a magnetic field.

A device for determining appropriate injection or testing sites. At least two movable adjacent plates are each provided with holes arranged in a certain system that can be brought in coincidence. A date carrier plate has numbers corresponding to the days of a month arranged in a certain system. A time carrier plate has numbers corresponding to the various times, mostly the hours, or parts of a day. After moving the plates a coincidence of holes in each determines the appropriate date and corresponding time for the optimal needle insertion point for the given date and time. Site determination signs defining a more exact needle insertion point on the various body parts are also provided.

Systems and methods encourage users to rotate injection sites and avoid lipodystrophy. Sleeves and/or lost-tooth gear dials and/or microswitches in or on injection pens or their caps, on vials, and on other portable devices manually adjust an indicator before or after an injection to show a current or next injection site in accordance with a site rotation plan. Injected medicine packaging and related printed indicia encourage site rotation. Optical devices employing optical mouse or projection technology help locate and/or distribute injection sites within a body area. A mobile phone app tracks injections and locations to select next injection site, and can use imaging to locate a target injection site and optionally diagnose lipodystrophic conditions and record them. Tactile and print media educational tools are presented to help users palpate and identify lipos in body areas having injection sites.

A medicament injection device in which the time elapsed is calculated from the end of a predetermined period during which medicament is permitted to disperse subsequent to completion of an injection stroke. The medicament injection device is particularly suitable for use by those with diabetes in which once a desired dosage of medicament has been selected and expelled from the medicament cartridge into the body of the patient, the injected medicament is allowed to disperse locally from the injection site within the patient's body before the needle arrangement is removed from the patient's body.

A medical syringe with a light source mounted on a distal end of the syringe to provide illumination of an injection site, a battery pack receiver configured to receive a battery pack with magnetic attraction a proximal end of the syringe, and a control circuit that is configured to illuminate the light source when the control circuit detects movement of the syringe and disconnects the battery from the light source either after a fixed period of time or after motion of the syringe ceases. Ideally the light source is a disc-shaped array of LED lights. The syringe is constructed of materials that can be sterilized.

The invention refers to an auto-injector (1) for administering a dose of a liquid medicament (M), comprising a tubular chassis (2) telescopable in a tubular case (12); a carrier subassembly comprising a tubular carrier (7) slidably arranged relative to the chassis (2) inside the case (12), the carrier (7) adapted to contain a syringe (3) with a hollow injection needle (4), a drive spring (8) and a plunger (9) for forwarding load of the drive spring (8) to a stopper (6) of the syringe (3), wherein the syringe (3) is lockable for joint axial translation with the carrier (7); a control spring (19) arranged around the carrier (7) for translating the carrier (7) in a proximal direction (P) for insertion of the needle (4) through the chassis (2) into an injection site, wherein the control spring (19) is arranged to bias the case (12) against the chassis (2) in a distal direction (D), so as to extend the chassis (2) out of a proximal end (P) of the case (12), wherein an insertion depth of the needle (4) is defined by the carrier (7) abutting the chassis (2) in a predefined position, wherein the case (12) is arranged to release or allow release of the control spring (19) for needle insertion on translation of the case (12) in the proximal direction (P) relative to the chassis (2) against the bias into an advanced position.

Garments are provided that permit easy accessibility to medicament injection sites, or key zones, of the wearer. Each of the garments has multiple access slots which overlie respective injection sites, e.g., arms, thighs, abdomen, and/or other body parts which tend to accumulate subcutaneous fat, making them suitable as injection sites. Each of the access slots has a base portion and a corresponding flap portion. Openings are defined through the access slots, between the base and flap portions, and provide access to the skin of the wearer at the respective injection sites. The access slots can be incorporated into the garment in a visually inconspicuous manner by providing them on or within covers that replicate the appearance of, e.g., pockets, patches, or other structures concealing their appearance.